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TMPRSS3 encodes a transmembrane serine protease that contains both LDLRA and SRCR domains and is
mutated in non-syndromic autosomal recessive deafness (DFNB8/10). To study its function, we cloned the
mouse ortholog which maps to Mmu17, which is structurally similar to the human gene and encodes a
polypeptide with 88% identity to the human protein. RT–PCR and RNA in situ hybridization on rat and mouse
cochlea revealed that Tmprss3 is expressed in the spiral ganglion, the cells supporting the organ of Corti and
the stria vascularis. RT–PCR on mouse tissues showed expression in the thymus, stomach, testis and E19
embryos. Transient expression of wild-type or tagged TMPRSS3 protein showed a primary localization in the
endoplasmic reticulum. The epithelial amiloride-sensitive sodium channel (ENaC), which is expressed in
many sodium-reabsorbing tissues including the inner ear and is regulated by membrane-bound channel
activating serine proteases (CAPs), is a potential substrate of TMPRSS3. In the Xenopus oocyte expression
system, proteolytic processing of TMPRSS3 was associated with increased ENaC mediated currents. In
contrast, 6 TMPRSS3 mutants (D103G, R109W, C194F, W251C, P404L, C407R) causing deafness and a mutant
in the catalytic triad of TMPRSS3 (S401A), failed to undergo proteolytic cleavage and activate ENaC. These
data indicate that important signaling pathways in the inner ear are controlled by proteolytic cleavage and
suggest: (i) the existence of an auto-catalytic processing by which TMPRSS3 would become active, and
(ii) that ENaC could be a substrate of TMPRSS3 in the inner ear.
INTRODUCTION
Hearing loss is the most common sensory defect in humans,
affecting about one in 1000 children (1). About 60% of all
cases of sensorineural deafness are of genetic origin (2) and
non-syndromic autosomal recessive deafness accounts for
70% of genetic hearing loss cases (2). Thirty-three loci
that cause autosomal recessive non-syndromic hearing loss
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have been identified and seventeen of these genes have been
isolated (http://dnalab-www.uia.ac.be./dnalab/hhh/index.html).
Mutations in the TMPRSS3 gene, which encodes a transmem-
brane serine protease, were identified in both familial and
sporadic cases of non-syndromic sensorineural recessive deaf-
ness, DFNB8/10 (3–6). TMPRSS3 (for transmembrane pro-
tease, serine 3) is a type II transmembrane serine protease
(TTSP) and like the other members of this family, it contains a
short N-terminal tail, a transmembrane (TM) domain and a large
C-terminal segment characterized by: (i) a stem region contain-
ing LDLRA and SRCR domains; (ii) a potential proteolytic
activation cleavage site between R216 and I217; and (iii) a
serine protease domain containing the catalytic triad signature
(H257, D304 and S401) (Fig. 1B). This structure suggests that
TMPRSS3 could be active as a membrane-bound enzyme (7).
Channel activating proteases (CAPs) are membrane-bound
serine proteases that are able to activate ENaC in vitro (8,9).
Recently, three CAPs have been identified in a mouse kidney
cell line (mCAP1, mCAP2, mCAP3) (10). Interestingly, like
TMPRSS3, mCAP2 is a type II transmembrane serine protease
incorporating LDLRA and SRCR domains. mCAP2 is the
mouse ortholog of hTMPRSS4. Recently, it has been suggested
that ENaC plays a role in the establishment and maintenance of
the remarkably low sodium concentration of the endolymph
(11,12). This observation raises the possibility that ENaC could
be a substrate of TMPRSS3 in the inner ear.
To study the function of TMPRSS3 in the inner ear, we
isolated the mouse Tmprss3 and characterized its expression
profile and the intracellular localization of the human
TMPRSS3 protein. We show that Tmprss3 co-localizes with
ENaC in some inner ear tissues and that, unlike wild-type
TMPRSS3, TMPRSS3 mutants causing deafness fail to
undergo proteolytic processing and to activate ENaC in vitro.
RESULTS
Isolation of the mouse Tmprss3 cDNA and gene
Using the methods described later, we constructed a 2752 bp
mouse Tmprss3 cDNA encoding a putative protein of 453 amino
acids that showed 88% identity to human TMPRSS3 (Fig. 1B) (3).
Similar to TMPRSS3, Tmprss3 is divided into 12 coding exons
over 18 kb of genomic sequence, but there was no experimen-
tal evidence for the existence of a 50UTR exon in the mouse
gene (Fig. 1A). No alternative mouse transcripts were identified.
Tmprss3 mRNA expression
RT–PCR was performed to study the expression profile of
Tmprss3. Significant expression was found in thymus, stomach,
testis, E19 embryos, stria vascularis, modiolus, organ of Corti
and cultured spiral ganglion (Figs. 2A and B). No amplification
from genomic DNA was observed.
To confirm these data, RNA in situ hybridization was
performed on mouse embryos and inner ear sections. Tmprss3
expression was not detected in the otocyst of mouse embryos
from E8.5 to E10.5 d.p.c. (data not shown). Further analyses
were performed on mouse postnatal day 5 when the inner ear
development is almost complete. Tmprss3 expression was
detected in the spiral ganglion and in the entire epithelium that
supports cells of the organ of Corti but was not observed in
sensory hair cells. Weak expression was also found in the stria
vascularis (Fig. 3).
Intracellular localization of human TMPRSS3 protein
The intracellular localization of the TMPRSS3 protein was
investigated by using wild-type and N- or C-terminal tagged
TMPRSS3 proteins. All TMPRSS3 proteins tested, showed
cytoplasmic localization in HeLa, Cos-7, U2OS and MDCK
cells (Fig. 4A–D, G and data not shown). Co-localization
experiments showed that the TMPRSS3 protein is primarily
localized in the endoplasmic reticulum membranes where it
may be anchored by its transmembrane domain (Fig. 4F and I
and data not shown).
Expression analysis of the a-, b- and c-ENaC
subunits in the rat inner ear
The ENaC channel is expressed in the inner ear and is known
to be regulated by serine protease activity. These features make
it a candidate substrate for TMPRSS3. To investigate this
possibility, the co-expression of Tmprss3 and the three ENaC
subunits was analysed by RT–PCR on a panel of rat inner ear
tissues. Similar to Tmprss3, a- and g-subunits were detected in
all the samples tested. The b-subunit was detected in all
samples tested except the organ of Corti and the spiral
ganglion, even after nested PCR (Fig. 2B).
Functional and biochemical analysis of
TMPRSS3 in Xenopus oocytes
The six TMPRSS3 missense mutations associated deafness can be
divided into three main groups: (i) LDLRA domain mutants
(D103G, R109W); (ii) an SRCR domain mutant (C194F); and
(iii) serine protease domain mutants (W251C, P404L, C407R)
(4–6), (Fig. 5A). Amino acid sequence comparisons of a portion
of the LDLRA, SRCR and serine protease domains of the human
and mouse TMPRSS3 with few selected such domains of other
proteins are available at http://medgen.unige.ch/ public_1.html
Co-expression of the human WT-TMPRSS3 cRNA with the
rat ENaC subunits (rENaC) led to an increase in ENaC
mediated current (INa) (P< 0.01) compared to oocytes injected
only with rENaC (Fig. 5B, lane 2 versus lane 1). Oocytes
injected only with water or TMPRSS3 did not generate
measurable current (data not shown). The LDLRA domain
mutants (D103G, R109W) retained a residual but significant
(P< 0.05) activity (lanes 3 and 4 versus lane 2). The SRCR
domain mutant (C194F) was totally inactive (lane 5 versus
lane 2). The catalytic domain mutants were either totally
inactive (W251C, P404L) (lanes 6 and 7 versus lane 2) or
partially active (C407R), leading to a small but significant
(P< 0.05) ENaC activation (lane 8 versus lane 2). As a
negative control, the S401A catalytic triad mutant was totally
inactive (lane 9 versus lane 2). Expression of the pro domain
(M1-S215) of TMPRSS3 (pro domain, pro) decreased baseline
activity (P< 0.01, lane 10 versus lane 1) whereas the serine
protease domain (M-C204-T454) of TMPRSS3 (SP domain,
SP) was inactive (lane 11 versus lane 2). As shown in
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Figure 5C, trypsin was able to activate ENaC significantly in
the absence of TMPRSS3 (lane 1). When ENaC was
co-expressed with WT-TMPRSS3, however, subsequent
exposure to trypsin had only a small additional effect (lane 2)
indicating a non-additive, common signalling pathway between
trypsin and TMPRSS3. By contrast, when ENaC was
co-expressed with TMPRSS3 mutants (lanes 3–9), pro
(lane 10) or SP domains (lane 11), sodium currents were
significantly enhanced by subsequent perfusion with trypsin.
When expressed in Xenopus oocytes, WT-TMPRSS3 was
detected as three protein species on a western blot analysis: a
predominant doublet of 50 and 54 kDa and a faint 30 kDa
fragment suggesting that a significant fraction of TMPRSS3 was
proteolytically processed (Fig. 5D). The faint 30 kDa fragment
migrated at the same position as the catalytic serine protease
domain (SP domain, lane 11) consistent with an auto-proteolytic
cleavage at the activation site between R216 and I217, as occurs
on other TTSPs (7). The 25 kDa non-catalytic subunit of
TMPRSS3 (pro domain, lane 10) could not be detected for
WT-TMPRSS3, suggesting additional proteolytic cleavage(s).
The unprocessed isoform of TMPRSS3 was detected for all
TMPRSS3 deafness mutants (lanes 3–8) and the S401A mutant
(lane 9) indicating that they were all well expressed but not
cleaved in the Xenopus oocyte expression system. These results
indicate that the LDLRA and SRCR domains and the serine
protease domain are all implicated in the ENaC channel
activation by TMPRSS3 and in the processing of TMPRSS3.
DISCUSSION
After our identification of TMPRSS3 as the gene responsible
for DFNB8/10 (3), we identified additional mutations in
TMPRSS3 (4–6) and pursued a variety of approaches to
investigate the role of TMPRSS3 in the hearing process. In this
paper, we report the isolation of the mouse ortholog and
subsequent expression studies. We also report that TMPRSS3
which may localize in the endoplasmic reticulum membranes,
undergoes cleavage and activates ENaC whereas the TMPRSS3
mutant proteins causing deafness are all unprocessed and
inactive. We also demonstrate that ENaC is co-expressed with
Tmprss3 in the inner ear.
The specific ion composition of the endolymph, characterized
by high potassium and low sodium concentrations, is essential
for the proper function of the sensory hair cells. Genes important
for potassium recycling are mutated in different forms of
syndromic and non-syndromic deafness (13,14). In contrast,
little is known about the transport systems and sites involved in
sodium homeostasis. The ENaC channel is a highly selective
sodium channel that is expressed in many sodium-reabsorbing
tissues and is a good candidate for sodium reabsorption from the
endolymph. Indeed, the three ENaC subunits mRNAs have been
detected in rat inner ear. Their expression levels were found to
increase from postnatal day 2 reaching the highest levels of
expression at postnatal day 12 when the concentration of sodium
in endolymph reaches adult levels (11,15). These data suggest
that ENaC may be involved in the regulation of sodium
concentration in the endolymph (11,12).
Using a Xenopus oocyte expression system, we showed that
TMPRSS3 is proteolytically cleaved and significantly activates
ENaC. In addition, we showed that TMPRSS3 missense
mutations causing deafness, that lie in all identified domains
except the TM, and a catalytic triad S401A mutant, all fail to
undergo proteolytic cleavage and to activate ENaC.
The mechanism of ENaC activation by TMPRSS3 remains
elusive and could be direct or indirect. TMPRSS3 anchored in
the endoplasmic reticulum membranes may play a role in the
processing of ENaC. ENaC is assembled and acquires core
glycosylation in the endoplasmic reticulum; this subunit
assembly occurs early in channel biosynthesis and is an
important determinant of ENaC maturation (16).
All the TMPRSS3 pathogenic missense mutations described
so far, D103G, R109W, C194F, W251C, P404L and C407R
(Figs. 5A), affect highly conserved residues except R109W in
the LDLRA domain and C407R in the serine protease domain
(4–6). Based on our functional screening of TMPRSS3 mutants
for their activation of ENaC in a Xenopus oocyte expression
system, the mutations can be classified into three groups:
(i) LDLRA domain mutants D103G and R109W which are
partially active; (ii) an SRCR domain mutant, C194F, which
Figure 1. (A) Schematic representation of the human and mouse TMPRSS3 genomic structure. Exons are represented as boxes numbered on top, with start and
stop/codons indicated. Introns are shown as thin lines. (B) Schematic representation of the mouse Tmprss3 protein showing the TM, LDLRA, SRCR and serine
protease domains and their position in the 453 amino acid polypeptide.
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changes a highly conserved residue and is totally inactive; and
(iii) two subgroups of serine protease domain mutants, the first
containing totally inactive mutants in which highly conserved
residues are affected, W251C and P404L, while the second
contains a partially active mutant, C407R, in which a
conserved amino acid is substituted (Fig. 5A–D).
In order to investigate whether ENaC could be a substrate of
TMPRSS3 in the inner ear, their respective expression profiles
were determined and compared. In 2001, Grunder et al. (11)
reported expression of the three ENaC subunits in the cochlea
of 12-day-old rats by RNA in situ hybridization. a-, b- and g-
ENaC subunits were identified in the supporting cells of the
organ of Corti, more specifically Deiters’ and Claudius’ cells.
Only a faint staining in the Claudius’ cells was observed for the
b subunit. Expression of the three subunits was also detected in
the spiral ganglion. However, none of the subunit was observed
in the sensory hair cells and no significant expression of any of
the three subunits was detected in the stria vascularis. In
agreement with these data, our RT–PCR study on inner ear
tissues of 5-day-old rats showed expression of the a- and g-
ENaC subunits in the organ of Corti and in the spiral ganglion
and a, b and g subunits in the stria vascularis. While b subunit
expression was observed in the organ of Corti and in the spiral
ganglion by in situ hybridization (11), our RT–PCR experiment
did show expression of the b subunit in these tissues. This
apparent discrepancy could be explained by the two different
stages of development studied, 12-day-old versus 5-day-old
rats, and/or by the fact that in situ hybridization is more
efficient at detecting expression in very few cells. Indeed,
Grunder et al. (11) found consistently that the b subunit was
only present in Claudius’ cells and not in the Deiters’ cells. In
any case, from our data and those of Grunder et al. (11), one
can propose that ENaC and TMPRSS3 co-localize in the spiral
ganglion, in the stria vascularis and in the supporting cells of
the organ of Corti. Interestingly, the stria vascularis and the
organ of Corti are two cochlear tissues that border the
endolymph and are implicated in sodium reabsorption (17–21).
ENaC is a heterotetrameric channel, a2bg but channel
activity can also be observed in the presence of heterodimers
a2b2 or a2g2 (22,23). As far as the response to trypsin in the
Xenopus oocyte expression system is concerned, we have found
that trypsin can activate a2bg channels in a similar manner to
the CAP proteins. Interestingly, a2b2 complexes are not
sensitive to trypsin or CAPs, whereas a2g2 complexes are
highly sensitive to trypsin or CAPs. If the oocyte experiments
are valid models for what happens in intact cells in vivo, one
could speculate that in the cochlea, a relatively small amount of
a2bg channels can be made. If the b subunit mRNA is limiting,
the predominant form would be an a2g2 channel which keeps
its trypsin/CAP sensitivity. Since both a2,b,g and a2,g2 can be
activated by CAPs (B.C. Rossier, unpublished observations), it
is reasonable to conclude that inner ear cells may express ENaC
with distinct subunit composition and thus different sodium
transport capacity but yet controlled by CAPs.
Little is known about the role of ENaC in the hearing
process. In mice, the concentrations of all the ions in
endolymph reach adult levels at day 7 after birth. In the
earliest postnatal days, the endolymphatic sodium concentration
is significantly higher than that in adult mice. a-ENaC (/),
b-ENaC (/) and g-ENaC (/) mice die within 40 h of
birth (24–26). Therefore, they are not convenient models to
study the role of ENaC in the development of the inner ear
sodium homeostasis which occurs during the first week of life.
To rescue cochlear hair cells from perinatal death of a-ENaC
(/), organotypic cultures were performed. Stimulation of the
outer hair cells in culture produced transducer currents that
were not different from those observed in controls, suggesting a
normal vestibular function and mechano-electrical trans-
duction (27). The human ENaC genes have been found to be
mutated in two distinct human diseases, Liddle’s syndrome
(OMIM#177200) and autosomal recessive pseudohypoaldos-
teronism type 1 (PHA-1) (OMIM#264350). In both conditions,
the ENaC activity is dysregulated leading to disorders of
systemic blood pressure (28). Until now, no severe hearing
impairment has been reported in those patients but evaluation
of less severe or selective impairment is currently underway in
PHA-1 patients. ENaC may be only one of several sodium
transporters involved in maintaining such an unusually low
sodium concentration and some redundancy would be highly
desirable in this context. In addition it is unlikely that ENaC is
the only substrate for TMPRSS3 in vivo.
Besides the ion transporters discussed above, other substrates
of TMPRSS3 in the inner ear could be neurotrophins. Studies
over the past decade have provided evidence that brain-derived
neurotrophic factor (BDNF) and neurotrophin 3 (NT-3) and their
associated high-affinity tyrosine kinase receptors (TrkB and
TrkC, respectively) are necessary for the normal development of
the afferent innervation of the inner ear (29). The biological
Figure 2. (A) RT–PCR analysis of mouse Tmprss3 expression. (B) RT–PCR
analysis of the expression of Tmprss3, ENaC a-, b- and g-subunits in mouse
(M.Kid) and rat kidney (R.Kid), stria vacsularis (St.Vascul.), modiolus, organ
of Corti (O.Corti), control cultured spiral ganglion (C.C.Sp.G) and BDNF-treated
cultured spiral ganglion (T.C.Sp.G). Nested PCR amplification is presented
for Tmprss3 and a-ENaC subunit. First PCR amplification is presented for
b- and g-ENaC subunits.
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action of neurotrophins is regulated by proteolytic cleavage of a
proform (proneurotrophins) to release the mature active neuro-
trophins. The serine protease plasmin, which belongs to the same
protease family as TMPRSS3, has been shown to cleave the
proform of BDNF (30). Neurotrophins, BDNF, NT-3 and their
associated receptors, TrkB and TrkC, are all expressed in the
organ of Corti and/or spiral ganglion (31–33). These data suggest
that TMPRSS3 might also be involved in the processing of
proneurotrophins and thus in the development and survival of
inner ear innervation.
The results reported in this study contribute to our under-
standing of the role of TMPRSS3 in the inner ear and the possible
etiology of DFNB8/10. We investigated the ENaC sodium
channel as a potential substrate of TMPRSS3 in the inner ear
focusing on the sodium homeostasis of the endolymph. Another
hypothesis, not tested here, is that TMPRSS3 is involved in
processing proneurotrophins and thus in the development and
survival of the cochlear neurons. The generation of a mouse with
targeted disruption of Tmprss3 will provide a suitable model to
investigate these and other hypotheses concerning the molecular
mechanisms causing deafness in DFNB8/10.
MATERIALS AND METHODS
Isolation of the mouse Tmprss3 cDNA and gene
A 220 kb mouse BAC clone, 556K2 (CITB-CJ7-B BAC library;
Research Genetics, Paisley, UK), that spans the region of mouse
chromosome 17q syntenic to the human TMPRSS3 locus on
human chromosome 21q22.3 has previously been reported (34).
It contains the Trefoil 3 gene, which in the human genome, is
60 kb centromeric to TMPRSS3. A 1 kb fragment of the mouse
Tmprss3 was PCR-amplified from BAC 556K2 using degene-
rate primers (50-TGYTGGAYNWSNGGNTGG-30, exon 9,
codons 338–343; and 50-CATYTGYTCRTGDATCCAATC-30,
exon 11, codons 442–448 of TMPRSS3). The full-length
Tmprss3 cDNA was isolated by 50 and 30 RACE. Tmprss3
introns were amplified from BAC 556K2 using primers based on
predicted Tmprss3 exons. Additional sequences were identified
by BLASTN analyses of the Celera Mouse database (http://
www.celera.com/). Sequences were assembled using the GAP4
Staden software (35). Sequences of the primers used are listed in
http://medgen.unige.ch/public_1.html
Expression pattern of Tmprss3
RT–PCR. RT–PCR with primers 50-CCTGGAGTCTATACG-
CGAATCAC-30 and 50-ATTGGGTGGAGATCTGAGATCTG-30
located within exons 11 and 12 of Tmprss3, respectively, was
performed on a normalized cDNA panel as described (36).
Intron 11 of Tmprss3 (3198 bp) is sufficiently large such that
amplification from genomic DNA should yield either no PCR
product or an easily distinguishable product.
RT–PCR was performed on RNA extracted from 5-day-old
rat modiolus, stria vascularis, organ of Corti and cultured spiral
ganglia cells, as described (37). PCRs for rat Tmprss3, were
performed using primers based on mouse nucleotide sequence.
PCRs for rat ENaC a-, b-, and g-subunits were performed
using primers based on rat nucleotide sequences (GenBank
Nos. NM_031548.1, X77932.1 and U37540.1, respectively).
Sequences of the primers used are listed in http://medgen.
unige.ch/public_1.html
RNA in situ hybridization. A 1.4 kb fragment from the 30UTR
of mouse Tmprss3 was amplified using primers 50-CTGAAGT-
GAACAAGCCTGGAGTC-30 and 50-TAGTCATCTCTTACT-
GTGACTAG-30 and cloned in TOPO TA PCRII vector
(Invitrogen, Paisley, UK). Digoxigenin-labelled sense and anti-
sense riboprobes were synthesized using T7 and SP6 RNA
polymerases, respectively. Heads of 5 day-old mice were fixed
Figure 3. RNA in situ hybridization of mouse Tmprss3 in cochlea of postnatal day-5-old mice. Tmprss3 mRNA was detected in the supporting cells of the organ of
Corti (panel A, magnification 10 and panel B, magnification 40), in the stria vascularis (panel A, magnification 10 and panel C, magnification 40) and in the
spiral ganglion (panel A, magnification 10 and panel D, magnification 60). St.V, stria vascularis; OC, organ of Corti; Sp.G, spiral ganglion; R.Mb, Reissner’s
membrane.
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in 4% paraformaldehyde, washed in PBS, dehydrated and paraf-
fin embedded. Sections, 8 mm thick, were mounted onto super-
frost slides. Slides were deparaffinated, rehydrated, acetylated
(0.25% acetic anhydride, 45 mM NaCl, 100 mM Tris, pH 8)
and washed in PBS. In situ hybridization was performed over-
night at 58C in 40% formamide, 5 SSC, 1 Denhardt’s,
100 mg/ml tRNA and the digoxigenin-labelled probe. After
washing once with 2 SSC at room temperature, twice with
2 SSC and twice with 0.1 SSC at 58C, sections were equi-
librated with Triton washing buffer (TWB), (0.05% Triton
X-100, l50 mM NaCl, 100 mM Tris, pH 7.5). Non specific bind-
ing sites were blocked with TWB containing 0.5% blocking
reagent (Roche, Rotkreuz, Switzerland) and sections were incu-
bated with anti-digoxigenin antibody for 2 h. After two washing
steps with TWB and equilibration with alkaline phosphatase
buffer NTMT (100 mM NaCl, 50 mM MgCl2, 100 mM Tris,
pH 9.5, 0.1% Tween 20), the slides were incubated with the sub-
strate (NBT/BCIP) overnight at room temperature. The reaction
was stopped in TE buffer (pH 8.5). Sections were dehydrated
and mounted. Images were recorded with a Hamamatsu digital
camera.
cDNA constructs. To visualize the subcellular localization
of TMPRSS3, four plasmids that express either tagged or
wild-type TMPRSS3 were constructed: WT-TMPRSS3 was
PCR-amplified and subcloned into vectors pECFP-N1
(Clontech, Palo Alto, California), pcDNA3X(þ)MycEGFP,
pcDNA3X(þ)HA and pcDNA3.1 (Invitrogen). For expression
studies, WT-TMPRSS3 was subcloned into pSD5 expression
vector (9). Mutants (D103G, R109W, C194F, W251C,
P404L, C407R, S401A) were generated using the
QuickChange mutagenesis kit (Stratagene, La Jolla, CA,
USA). Two truncated TMPRSS3 constructs (pro domain M1-
S215: TMPRSS3 without the catalytic domain and SP
Figure 4. Intracellular localization of TMPRSS3 protein. Fluorescence micro-
scopic analysis of fixed Cos-7 cells transiently transfected with pWT-TMPRSS3
(panel A, green signal), p50EGFP-TMPRSS3 (panel B, green signal) and
p50HA-TMPRSS3 (panel C, red signal) and counterstained with 4,6-diamidoni-
2-phenylindole (DAPI) (panels A, B and C, blue signal). Fixed Cos-7 cells
transiently transfected with pEGFP-TMPRSS3 (panel D, green signal) and
counterstained with endoplasmic reticulum marker (ER-Tracker, panel E, blue
signal). Co-localisation of EGFP-TMPRSS3 with ER marker is shown in
panel F. Fixed HeLa cells transiently co-transfected with pTMPRSS3-
30ECFP and pYFP-ER (panels G–I). TMPRSS3-ECFP signal is shown in
panel G. pYFP signal is shown in panel H. Co-localisation of TMPRSS3-ECFP
with the ER marker is shown in panel I.
Figure 5. Functional expression of TMPRSS3 in Xenopus oocytes. (A)
Predicted structure of TMPRSS3. Numbers indicate the amino acid positions.
The serine protease catalytic triad residues (H257, D304 and S401), the pre-
dicted disulfide bridge which links the pro- and catalytic domains of
TMPRSS3 and the tested human deafness associated TMPRSS3 missense
mutations D103G, R109W, C194F, W251C, P404L and C407R are shown.
TM, transmembrane domain; LDLRA, low-density lipoprotein receptor class
A domain; SRCR; scavenger receptor cysteine-rich domain; pro, pro-domain;
SP, serine protease domain. (B) Comparison of the effect of WT-TMPRSS3
and mutants on INa in Xenopus oocytes. Oocytes were injected with rat
ENaC subunits in the presence of either water (lane 1, white column),
WT-TMPRSS3 (lane 2), TMPRSS3 missense deafness associated mutants
(lanes 3–8), serine catalytic mutant (lane 9), pro domain construct (lane 10)
or serine protease domain construct (SP) of TMPRSS3 (black columns).
**¼P< 0.01; *¼P< 0.05 versus 1. Lanes l–9 and 11, (n 25); lane 10,
(n¼ 16). (C) Measure of the fold increase of ENaC-mediated INa in injected
oocytes after 3 min of perfusion of trypsin. Same conditions as described under
B. **¼P< 0.01. Lanes 1–9 and 11, (n 16); lane 10, (n¼ 10). (D)
Biochemical analysis of WT and mutants TMPRSS3 by western blot on protein
extracts from pools of 10 injected oocytes. Pro-SP, pro-serine protease; pro,
pro-domain; SP, serine protease domain, Same conditions as described under B.
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domain M-C204-T454: TMPRSS3 catalytic domain alone)
were generated by PCR and subcloned into PSD5 vector
(Fig. 5A). All constructs were verified by DNA sequencing.
Sequences of the primers and restriction enzymes used are
listed in http://medgen.unige.ch/public_1.html
Human TMPRSS3 polyclonal antibodies. Two polyclonal
antibodies were raised in rabbits against a mixture of
two synthetic peptides NH2-MGENDPPAVEAPFSFC-COOH
(amino acids 1–16 of human TMPRSS3) and NH2-CFLDWI-
HEQMERDLKT-COOH (amino acids 439–454 of human
TMPRSS3) (CovalAb, Lyon, France, http://www.covalab.com).
Subcellular localization of TMPRSS3 protein. Cos-7, U2OS
and MDCK cells were transfected with 0.5 mg of 50
MycEGFP-TMPRSS3 or 50 HA-TMPRSS3 or WT-TMPRSS3
using LipofectAMINE PLUS reagent (Life Technologies,
Paisley, UK, #10964-013) and fixed in 4% paraformaldehyde.
50 MycEGFP-TMPRSS3 fluorescence was detected using
epifluorescence microscopy (Zeiss Axiophot I, color
Axiocam). 50 HA-TMPRSS3 was detected using anti-HA
antibody (Santa Cruz Biotechnology, Santa Cruz, CA, USA,
#sc7392) followed by a rhodamine-conjugated secondary anti-
bodies (Santa Cruz Biotechnology, #sc-2093). WT-TMPRSS3
was detected using rabbit anti-TMPRSS3 serum (CovalAb)
followed by fluorescein isothiocyanate-conjugated secondary
antibodies (Santa Cruz Biotechnology, #sc-2090). Images were
processed with the Adobe Photoshop software.
To perform co-localization experiments, transfected cells
were incubated with markers for the Golgi apparatus (mouse
anti-Giantin antibody, Calbiochem, San Diego, CA, USA,
#324450) followed by rhodamine-conjugated secondary anti-
body (Santa Cruz #sc-2093) or the endoplasmic reticulum
(ER-Tracker Blue-White DPX, Molecular Probes, Eugene, OR,
USA, #E-2353). Alternatively, HeLa and Cos-7 cells were co-
transfected with 1 mg of pTMPRSS3-ECFP-N1 and marker
vectors including pEYFP-Peroxi, pEYFP-Mito, pEYFP-Golgi,
pEYFP-ER, or pEYFP-Mem (Clontech) using Fugene 6
(Roche). Empty expression vectors were used as negative
controls.
Electrophysiological measurements in Xenopus oocytes.
Expression studies were performed in stage V/VI oocytes iso-
lated from Xenopus laevis (Noerdhoek, South Africa). Oocytes
were injected with 0.25 ng of each cRNA coding for the rat a-,
b- and g-ENaC subunits in the presence or absence of 2.5 ng
of wild-type or mutant TMPRSS3 cRNA in a total volume of
l00 nl. Oocytes were incubated in modified Barth saline
(MBS) solution and 48 h after injection, electrophysiological
measurements were performed. Using the two-electrode voltage
clamp technique, the amiloride-sensitive current (INa) was mea-
sured in the presence of 120 mM of Naþ in Frog Ringer with
5 mM amiloride at a holding potential of 100 mV. The oocytes
were perfused with 2 mg/ml of trypsin during 2–3 min and INa
was re-measured. All results are reported as means	 SEM.
Comparing independent sets of data, unpaired t-tests were used
to determine significance. In experiments where oocytes were
perfused with trypsin, paired t-tests were used. (n) Represents
the number of experiments performed.
Western blot analysis. Injected oocytes were incubated
in MBS for 48 h. Microsomal membrane protein extracts
were obtained from pools of 10 injected oocytes lysed as
described (38). Proteins were separated on a 10% SDS-polya-
crylamide gel under reducing and denaturing conditions and
transferred to nitrocellulose membrane. The membrane was
processed using rabbit anti-TMPRSS3 serum (Covalab) ac-
cording to standard procedures.
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